Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.55 |
| ▸ | TSHR | P16473 | 2/20 | 0.55 |
| ▸ | MEN1 | O00255 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.51 |
| ▸ | POLB | P06746 | 2/20 | 0.49 |
| ▸ | MAPT | P10636 | 2/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.49 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.46 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.46 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.46 |
| ▸ | CA1 | P00915 | 3/20 | 0.44 |
| ▸ | CA2 | P00918 | 3/20 | 0.44 |
| ▸ | CA4 | P22748 | 3/20 | 0.44 |
| ▸ | CA7 | P43166 | 3/20 | 0.44 |
| ▸ | CA9 | Q16790 | 3/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | PLA2G4B | P0C869 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11566950 | 0.89 | MAPT (0.50) | TDP1TSHRPOLBMAPTLMNA | |
| SCHEMBL7934862 | 0.87 | MAPT (0.55) | TDP1TSHRPOLBMAPTLMNA | |
| SCHEMBL6049252 | 0.84 | TDP1 (0.55) | TDP1TSHRPOLBMAPTLMNA | |
| SCHEMBL15140443 | 0.83 | MEN1 (0.51) | TDP1TSHRMEN1KMT2APOLB | |
| SCHEMBL28531572 | 0.82 | POLB (0.51) | TDP1TSHRPOLBMAPTLMNA | |
| SCHEMBL11959217 | 0.82 | LMNA (0.58) | TSHRMEN1KMT2APOLBMAPT | |
| SCHEMBL1263762 | 0.81 | POLB (0.47) | TDP1TSHRMEN1KMT2APOLB | |
| SCHEMBL11018105 | 0.80 | KMT2A (0.49) | TDP1TSHRMEN1KMT2APOLB | |
| SCHEMBL9248709 | 0.80 | HTT (0.61) | TSHRMEN1KMT2APOLBMAPT | |
| SCHEMBL29620622 | 0.80 | LTA4H (0.58) | MEN1KMT2APOLBMAPTLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109641855-B | Azo compounds, polymers, and processes for their preparation and use | 东莞东阳光医疗智能器件研发有限公司 | 2022-04-29 | — | — | CN | disclosed |
| CN-110382628-B | Polymerizable dye compound, preparation method, polymer containing dye and application | 东莞东阳光医疗智能器件研发有限公司 | 2021-03-02 | — | — | CN | disclosed |
| EP-1295870-B1 | SUPLATAST TOSILATE CRYSTALS | TAIHO PHARMACEUTICAL CO LTD (JP) | 2007-12-19 | — | — | EP | disclosed |
| US-20030149105-A1 | Suplatast tosilate crystals | TAIHO PHARMACEUTICAL CO., LTD. (JP) | 2003-08-07 | — | — | US | disclosed |
| US-6593326-B1 | Useful as anti-cancer agents; and processes for their manufacture and pharmaceutical compositions containing them are described. Apoptotic effect in a warm-blooded animal such as man. | ASTRAZENECA AB (SE) | 2003-07-15 | — | — | US | disclosed |
| EP-1295870-A1 | SUPLATAST TOSILATE CRYSTALS | TAIHO PHARMACEUTICAL COMPANY LIMITED (JP) | 2003-03-26 | — | — | EP | disclosed |
| EP-0178073-B1 | AMIDE COMPOUNDS, PROCESS FOR PREPARING THE SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME | TAIHO PHARMACEUTICAL COMPANY, LIMITED (JP) | 1988-04-27 | — | — | EP | disclosed |
| US-4670583-A | ANTIALLERGENS | TAIHO PHARMACEUTICAL COMPANY, LIMITED (JP) | 1987-06-02 | — | — | US | disclosed |
| EP-0178073-A1 | amide compounds, process for preparing the same and pharmaceutical compositions containing the same | TAIHO PHARMACEUTICAL COMPANY, LIMITED (JP) | 1986-04-16 | — | — | EP | disclosed |
| US-4556737-A | ANTIALLERGENS, TREATMENT OF ASTHMA AND RHINITIS | TAIHO PHARMACEUTICAL COMPANY LIMITED (JP) | 1985-12-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030149105-A1 | Suplatast tosilate crystals | SART3, SOST, PRPF19 | TDP1 477/4885TSHR 314/4885MEN1 2445/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.